Skip to main content
. 2022 Jun 1;8(1):e12296. doi: 10.1002/trc2.12296

FIGURE 1.

FIGURE 1

Consolidated Standards of Reporting Trials (CONSORT) diagram of phase 2, randomized, double‐blind, placebo‐controlled study to evaluate bosutinib effects on safety, tolerability, biomarkers, and clinical outcomes in dementia with Lewy bodies